This is further evident from a COVID-19 seroprevalence study conducted in Bangladesh, which suggested that the seroprevalence of COVID-19 IgG and/or IgM was 45% in the Dhaka city whereas it was 74% in the urban slums [14]. The gene discussed is CD40LG; the disease is COVID-19.